Welcome to the ValueWiki Novelos Therapeutics, Inc. (NVLT) article! Register for free or click the "edit" link to contribute!

Novelos Therapeutics, Inc. (NVLT)

This summary section needs content! Click Here to begin writing.

Have a question about Novelos Therapeutics, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

12/12/08 8:12 am	Novelos Therapeutics Announces Presentation of Positive Results in Ongoing Phase 2 Neoadjuvant Breast Cancer Trial at San Antonio Breast Cancer Symposium (Business Wire)
12/04/08 8:12 am	Novelos Therapeutics and Academic Collaborators Present Posters at 2008 AACR Tumor Immunology Conference (Business Wire)
11/22/08 9:11 am	NOVELOS THERAPEUTICS, INC. Financials (EDGAR Online Financials)
11/04/08 8:11 am	Novelos Therapeutics to Present at Rodman & Renshaw 10th Annual Healthcare Conference (Business Wire)
08/18/08 8:08 am	NOVELOS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equit (EDGAR Online)
03/28/08 8:03 am	NOVELOS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, (EDGAR Online)
03/24/08 3:03 pm	NOVELOS THERAPEUTICS, INC. Files SEC form 10KSB, Annual Report (EDGAR Online)
12/20/07 4:12 pm	NOVELOS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)